No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms

被引:34
作者
Chen, KT
Tuomala, RE
Cohen, AP
Eichenwald, EC
Lieberman, E
机构
[1] Harvard Univ, Sch Med,Div Maternal Fetal Med, Brigham & Womens Hosp, Dept Obstet Gynecol & Reprod Biol, Boston, MA 02115 USA
[2] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Newborn Med, Boston, MA 02115 USA
关键词
group B Streptococcus; Streptococcus agalactiae; Escherichia coli; pregnancy complications; ampicillin resistance; drug therapy;
D O I
10.1067/mob.2001.117354
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: We assessed the impact of a risk-based approach to group B Streptococcus (GBS) prophylaxis on the rates of early-onset neonatal sepsis (EONS). STUDY DESIGN: A retrospective cohort study of neonates born at a tertiary-care hospital from 1990 to 1996 was performed. Cases of EONS were identified among neonates born in a period without GBS prophylaxis (1990-1992) and compared with those born in a period with GBS prophylaxis (1993-1996). The antibiotic susceptibility data on each organism isolated in the blood culture were obtained. RESULTS: In the period without prophylaxis, 99 cases of EONS were identified among 25,934 neonates for a rate of 3.8 per 1000 births. In the period with prophylaxis, 90 cases of EONS occurred among 34,262 neonates for a rate of 2.6 per 1000. The rate of GBS-EONS significantly decreased between the 2 periods (from 1.9 to 1.1, P =.01). There was a trend toward a decrease in the rate of EONS caused by non-GBS gram-positive organisms (from 1.2 to 0.7, P =.06). There was no significant increase in the rate of EONS caused by gram-negative or ampicillin-resistant organisms. CONCLUSIONS: A risk-based approach to GBS prophylaxis reduced the incidence of GBS-EONS at a tertiary-care hospital. This decrease was not accompanied by an increase in the incidence of EONS by non-GBS or ampicillin-resistant organisms.
引用
收藏
页码:854 / 858
页数:5
相关论文
共 31 条
  • [1] *AM COLL OBST GYN, 1992, ACOG TECHN B, V170
  • [2] [Anonymous], INFECT DIS FETUS NEW
  • [3] PREVENTION OF EARLY-ONSET NEONATAL GROUP-B STREPTOCOCCAL DISEASE WITH SELECTIVE INTRAPARTUM CHEMOPROPHYLAXIS
    BOYER, KM
    GOTOFF, SP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (26) : 1665 - 1669
  • [4] NON-GROUP D-ALPHA-HEMOLYTIC-STREPTOCOCCI - NEW NEONATAL PATHOGENS
    BROUGHTON, RA
    KRAFKA, R
    BAKER, CJ
    [J]. JOURNAL OF PEDIATRICS, 1981, 99 (03) : 450 - 454
  • [5] *CTR DIS CONTR PRE, 1996, MMWR-MORBID MORTAL W, V45, P1
  • [6] GILBERT DN, 1999, ANTIMICROBIAL THERAP, P52
  • [7] A 10-YEAR REVIEW OF NEONATAL SEPSIS AND COMPARISON WITH THE PREVIOUS 50-YEAR EXPERIENCE
    GLADSTONE, IM
    EHRENKRANZ, RA
    EDBERG, SC
    BALTIMORE, RS
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1990, 9 (11) : 819 - 825
  • [8] HALL CB, 1992, PEDIATRICS, V90, P775
  • [9] Hall R T, 1987, J Perinatol, V7, P122
  • [10] THE NORMAL VAGINAL FLORA, H2O2-PRODUCING LACTOBACILLI, AND BACTERIAL VAGINOSIS IN PREGNANT-WOMEN
    HILLIER, SL
    KROHN, MA
    RABE, LK
    KLEBANOFF, SJ
    ESCHENBACH, DA
    [J]. CLINICAL INFECTIOUS DISEASES, 1993, 16 : S273 - S281